Suppr超能文献

基于活性的激酶组分析:使用化学蛋白质组学和ATP酰基磷酸盐

Activity-Based Kinome Profiling Using Chemical Proteomics and ATP Acyl Phosphates.

作者信息

Franks Caroline E, Hsu Ku-Lung

机构信息

Department of Chemistry, University of Virginia, Charlottesville, Virginia.

出版信息

Curr Protoc Chem Biol. 2019 Sep;11(3):e72. doi: 10.1002/cpch.72.

Abstract

Human kinases are a large family of proteins (500+) that catalyze ATP-dependent phosphorylation of protein and metabolite substrates to regulate diverse facets of cell biology. Dysregulation and mutations of protein kinases are linked to human disease, providing opportunities for developing pharmacological agents as potential therapy. Assessing the selectivity of pharmacological compounds targeting this enzyme class is critical given that off-target activity of kinase inhibitor drugs may result in toxicity. This set of protocols outlines use of ATP acyl phosphate activity-based probes to evaluate the potency and selectivity of kinase inhibitors via fluorescent gel- and mass spectrometry-based detection methods. These competitive chemical proteomic assays can evaluate engagement of >200 native kinase targets directly in complex proteomes. © 2019 by John Wiley & Sons, Inc.

摘要

人类激酶是一个庞大的蛋白质家族(超过500种),可催化蛋白质和代谢物底物的ATP依赖性磷酸化,以调节细胞生物学的多个方面。蛋白激酶的失调和突变与人类疾病相关,这为开发潜在治疗药物提供了机会。鉴于激酶抑制剂药物的脱靶活性可能导致毒性,评估针对这类酶的药理化合物的选择性至关重要。本套方案概述了基于ATP酰基磷酸活性的探针的使用,通过基于荧光凝胶和质谱的检测方法来评估激酶抑制剂的效力和选择性。这些竞争性化学蛋白质组学分析可以直接在复杂蛋白质组中评估超过200种天然激酶靶点的结合情况。© 2019约翰威立父子公司版权所有

相似文献

2
The Ligand Binding Landscape of Diacylglycerol Kinases.二酰基甘油激酶的配体结合景观。
Cell Chem Biol. 2017 Jul 20;24(7):870-880.e5. doi: 10.1016/j.chembiol.2017.06.007. Epub 2017 Jul 14.
8
Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics.通过化学蛋白质组学解析脂质激酶抑制剂
Biochemistry. 2018 Jan 16;57(2):231-236. doi: 10.1021/acs.biochem.7b00962. Epub 2017 Nov 22.
9
Large-scale proteomics analysis of the human kinome.人类激酶组的大规模蛋白质组学分析。
Mol Cell Proteomics. 2009 Jul;8(7):1751-64. doi: 10.1074/mcp.M800588-MCP200. Epub 2009 Apr 15.

引用本文的文献

1
Advancing Covalent Ligand and Drug Discovery beyond Cysteine.超越半胱氨酸推进共价配体与药物发现
Chem Rev. 2025 Jul 23;125(14):6653-6684. doi: 10.1021/acs.chemrev.5c00001. Epub 2025 May 22.

本文引用的文献

1
Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.发现具有泛 TAIRE 家族特异性的共价 CDK14 抑制剂。
Cell Chem Biol. 2019 Jun 20;26(6):804-817.e12. doi: 10.1016/j.chembiol.2019.02.015. Epub 2019 Mar 28.
3
Evolution of Small Molecule Kinase Drugs.小分子激酶药物的演变
ACS Med Chem Lett. 2018 Dec 18;10(2):153-160. doi: 10.1021/acsmedchemlett.8b00445. eCollection 2019 Feb 14.
5
Isoform-selective activity-based profiling of ERK signaling.基于活性的ERK信号通路亚型选择性分析
Chem Sci. 2018 Feb 6;9(9):2419-2431. doi: 10.1039/c8sc00043c. eCollection 2018 Mar 7.
6
The target landscape of clinical kinase drugs.临床激酶药物的目标格局。
Science. 2017 Dec 1;358(6367). doi: 10.1126/science.aan4368.
7
Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics.通过化学蛋白质组学解析脂质激酶抑制剂
Biochemistry. 2018 Jan 16;57(2):231-236. doi: 10.1021/acs.biochem.7b00962. Epub 2017 Nov 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验